Issues related to COVID-19 vaccines.
2025 · 2nd Quarter (Apr 1 - June 30)
NOVAVAX, INC.
Filed by CROSSROADS STRATEGIES, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Termination
- Posted
- Jul 20, 2025
- Income
- $20,000.00
- Expenses
- Not reported
- Registrant
- CROSSROADS STRATEGIES, LLC
- Client
- NOVAVAX, INC.
- Filing UUID
- ae8fb974-5fa4-453b-bc42-3431aa9b2b8a
- Termination date
- Apr 30, 2025
Literal source text
Lobbying issues and bill citations
FY2025 Budget Reconciliation Process; all bio-pharmaceutical related provisions.
Issues related to tariffs.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.